Owens & Minor ($NYSE:OMI) is a publicly-traded company, listed on the New York Stock Exchange (NYSE) under the ticker symbol OMI. It generates most of its revenue from the sale of physician preference items, services, and national brand products to healthcare providers. If Owens & Minor meets or exceeds its predicted EPS, it would mark the fifth straight year of earnings growth for the company. Investors should monitor Owens & Minor’s progress towards meeting its EPS guidance closely in the coming months.
In its earning report for the Q2 of FY2023 ending June 30th 2021, Owens & Minor reported total revenue of 2489.46M USD and net income of 65.9M USD. Compared to the same period in the previous year, total revenue decreased by 0.4%, while net income increased by 130.4%. Over the past 3 years, total revenue has grown from 2489.46M USD to 2563.23M USD.
In light of these numbers, Owens & Minor has updated its earnings guidance for FY2023, expecting earnings per share to range between $1.30 and $1.55. The company is confident that these figures are achievable and will continue to monitor progress and performance closely.
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for OMI. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for OMI. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for OMI. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for OMI are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
On Monday, OWENS & MINOR (OMI) stock opened at $18.6 and closed at $19.2, up 1.2% from last closing price of 19.0. The company made an announcement related to its fiscal year 2021 earnings guidance, expecting a diluted earnings per share (EPS) between $1.30 and $1.55. The company also stated that the current economic climate presents both opportunities and challenges for their business. Nevertheless, they are continuing to focus on their strategies for revenue growth, margin expansion, and capital deployment to drive long-term returns for their shareholders. Live Quote…
Analysis – OMI Stock Fair Value Calculation
At GoodWhale, we have conducted an analysis of OWENS & MINOR’s financials. Our proprietary Valuation Line has determined that the fair value of an OWENS & MINOR share is around $30.9. That being said, the current stock price sits at $19.2, resulting in a 37.8% undervaluation of their shares. This presents a great opportunity for investors to purchase OWENS & MINOR stock and gain the benefit of potential growth in the future. More…
Risk Rating Analysis
Star Chart Analysis
Owens & Minor Inc is in the business of distributing medical supplies and providing related services to healthcare providers. The company operates in North America and Europe. Its competitors include Orthofix Medical Inc, Medirect Latino Inc, PT Millennium Pharmacon International Tbk.
– Orthofix Medical Inc ($NASDAQ:OFIX)
Orthofix Medical Inc is a medical device company that provides orthopedic solutions to patients worldwide. The company has a market cap of 297.51M as of 2022 and a Return on Equity of -4.8%. The company’s products are used in the treatment of various conditions, including osteoarthritis, degenerative disc disease, scoliosis, and deformities. The company’s products are sold through a network of distributors and retailers.
– Medirect Latino Inc ($OTCPK:MLTO)
PT Millennium Pharmacon International Tbk is a leading pharmaceutical company in Indonesia with a market cap of 156.7B as of 2022. The company has a strong focus on research and development, and has a strong portfolio of products. The company has a Return on Equity of 17.77%.
Owens & Minor, Inc. is a healthcare services company that provides supply chain and other services to healthcare providers and manufacturers. This suggests that Owens & Minor is expecting increased profitability in the near future and may be a good candidate for investors looking for a company with strong potential. Analysts will be closely watching the company’s progress and will likely be keen to issue further updates on its performance, providing further guidance for investors.